Weitere Meldungen

14:41		Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness
14:36		New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
21.09.18		Dassault Aviation: About the Rafale contract for India
21.09.18		Ifis Npl finalized three new deals in September for € 1.26 billion. The portfolio exceeds € 14.7 billion of non-performing exposures
21.09.18		FRO - Changes to the Board composition
21.09.18		GOGL - Changes to the Board composition
21.09.18		ITCL - 2018 Annual General Meeting
21.09.18		FRO - 2018 Annual General Meeting
21.09.18		GOGL - 2018 Annual General Meeting
21.09.18		Bombardier Delivers First 90-seat Q400 Aircraft to SpiceJet
21.09.18		Spark Therapeutics Announces Positive CHMP Opinion for One-time Gene Therapy LUXTURNA® (voretigene neparvovec) in the European Union
21.09.18		Sandoz receives positive CHMP opinion for proposed biosimilar pegfilgrastim
21.09.18		Novartis receives positive CHMP opinion for Gilenya® for the treatment of children and adolescents with MS, marking a major medical advance for young MS patients in Europe
21.09.18		Novartis announces positive CHMP opinion for one-time gene therapy Luxturna® to treat children and adults with rare inherited retinal disease
21.09.18		Oasmia Pharmaceutical Receives Positive CHMP Opinion for Apealea® (paclitaxel micellar) in the European Union
21.09.18		Spark Therapeutics Announces Positive CHMP Opinion for One-time Gene Therapy LUXTURNA® (voretigene neparvovec) in the European Union
21.09.18		ContextVision AB - Company presentation held at Norne Securities' Vekst & Verdi Aksjeseminar in Vilnius
21.09.18		The arbitration proceedings between Valmet and Suzano Papel e Celulose S.A. have ended
21.09.18		GLOBAL BIOENERGIES: GLOBAL BIOENERGIES announces a successful private placement for around €6.2 million
21.09.18		COPPERSTONE RESOURCES AB: DRILLHOLE COS18364 RETURNS 103m WITH 0.42% COPPER MINERALISATION EAST OF GRANLIDEN HILL
21.09.18		Stillfront Group AB: Stillfront Group acquires Imperia Online JSC
21.09.18		AGENDA FOR THE ANNUAL GENERAL MEETING OF EUROCOMMERCIAL PROPERTIES N.V.
21.09.18		Shire Receives Approval of FIRAZYR® (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan
21.09.18		AMG Advanced Metallurgical Group N.V. Completes Multi-Year Agreement for 100% Renewable Energy Contract for UK Operations
21.09.18		Medtronic to Acquire Mazor Robotics
20.09.18		XBiotech gibt Erweiterung seines Teams um Top-Dermatologin und Forscherin Dr. Alice Gottlieb bekannt
20.09.18		PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights
20.09.18		Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA™ (eravacycline) for the Treatment of Complicated Intra-A
20.09.18		ERYTECH gibt Aufnahme des ersten Patienten in seine klinische Phase-3-Studie zur Untersuchung von Eryaspase als Zweitlinientherapie bei Pankreaskrebs bekannt
20.09.18		KBC Group: Publication of transparency notification(s) received by KBC Group NV
20.09.18		Oxurion nv Enrolls First Patient in Phase 1 Clinical Trial Evaluating THR-687, a Novel Pan-RGD Integrin Antagonist, for Treatment of Diabetic Macular Edema (DME)
20.09.18		HPIL Holding unterzeichnet Absichtserklärung mit Numbers Unlimited Limited aus dem Vereinigten Königreich
20.09.18		Net Insight's Nimbra 1060 Wins TVB Europe's Best of Show Award
20.09.18		Sale of Rotterdam tank terminal is finalized
20.09.18		Rapid7 Brings Security Orchestration and Automation Capabilities to its Insight Platform
20.09.18		Uniserve launches Managed Small Business Solutions
20.09.18		Hitachi Vantara Delivers Digital Evidence Management To Enable More Effective Policing
20.09.18		SeaBird Exploration: Letter of intent received for source work in the Americas region
20.09.18		Novo Nordisk - Oral semaglutide demonstrates greater reductions in HbA1c and body weight and comparable number of adverse events vs dulaglutide in Japanese people with type 2 diabetes
20.09.18		Acarix CADScor®System for early rule-out of Coronary Artery Disease (CAD) gains traction from established German users.
20.09.18		XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
20.09.18		Outotec continues Employee Share Savings Plan in 2019
20.09.18		Vestas secures 144 MW order from Avangrid Renewables in the USA
20.09.18		Health Canada has authorized TAKHZYRO(TM) (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks
20.09.18		Hiab stellt MULTILIFT Ultima vor - eine Revolution bei Produktivität, Benutzerfreundlichkeit und Sicherheit
20.09.18		Wolters Kluwer N.V.: Share Buyback Transaction Details September 13 – September 19, 2018
20.09.18		Vestas and MHI Vestas Offshore Wind change setup on Isle of Wight to make room for future offshore expansion
20.09.18		INVITATION TO INVESTOR BRIEFING IN LONDON FOR INVESTORS AND ANALYSTS ON 10 OCTOBER 2018
20.09.18		Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018
20.09.18		Nokia and Altran introduce joint solution to streamline train maintenance for railways

1 | Weiter

Newssuche

Aktuelle News zu

Top-News

18:05		KW 38: Das sind die Tops und Flops im DAX
12:43		So bewegen sich die Kurse von Bitcoin, Litecoin, Bitcoin Cash und Ethereum am Samstag
10:00		Umfrage zum Thema (Barrier) Reverse Convertibles (Anzeige)
08:51		Glencore legt Preis für Wandelanleihe bei 179'408,46 Dollar pro Bond fest
07:30		SMI beendet die Handelswoche nahezu unbewegt -- DAX im Plus

Wie bewerten Sie diese Seite?

schlecht sehr gut

Aktien SMI SPI SLI SMIM DAX EuroStoxx 50 Dow Jones Nasdaq 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung Schweizer Börse: 20 Min., Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2018 finanzen.net GmbH

SMI SMI Realtime Goldpreis Aktien Kursliste SMI Devisen Dollarkurs Eurokurs Silberpreis Fonds Strukturierte Produkte Warrants Rohstoffe Portfolio Währungsrechner Aktienkurse Ölpreis Leitzins Börsenkurse

Weitere Meldungen

Newssuche

Meistgelesene Nachrichten

Aktuelle News zu

Top-News